These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 14645696

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cyclin D1 over-expression correlates with beta-catenin activation, but not with H-ras mutations, and phosphorylation of Akt, GSK3 beta and ERK1/2 in mouse hepatic carcinogenesis.
    Gotoh J, Obata M, Yoshie M, Kasai S, Ogawa K.
    Carcinogenesis; 2003 Mar; 24(3):435-42. PubMed ID: 12663502
    [Abstract] [Full Text] [Related]

  • 5. Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.
    Saldanha G, Ghura V, Potter L, Fletcher A.
    Br J Dermatol; 2004 Jul; 151(1):157-64. PubMed ID: 15270885
    [Abstract] [Full Text] [Related]

  • 6. beta-Catenin alteration in cancer of the ampulla of Vater.
    Kawakami M, Kimura Y, Furuhata T, Zenbutsu H, Yanai Y, Mukaiya M, Satoh Y, Murata S, Hirata K.
    J Exp Clin Cancer Res; 2002 Mar; 21(1):23-7. PubMed ID: 12071524
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Significance of aberrant (cytoplasmic/nuclear) expression of beta-catenin in pancreatoblastoma.
    Tanaka Y, Kato K, Notohara K, Nakatani Y, Miyake T, Ijiri R, Nishimata S, Ishida Y, Kigasawa H, Ohama Y, Tsukayama C, Kobayashi Y, Horie H.
    J Pathol; 2003 Feb; 199(2):185-90. PubMed ID: 12533831
    [Abstract] [Full Text] [Related]

  • 11. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.
    Bissonnette M, Khare S, von Lintig FC, Wali RK, Nguyen L, Zhang Y, Hart J, Skarosi S, Varki N, Boss GR, Brasitus TA.
    Cancer Res; 2000 Aug 15; 60(16):4602-9. PubMed ID: 10969813
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CTNNB1 mutations and beta-catenin expression in endometrial carcinomas.
    Machin P, Catasus L, Pons C, Muñoz J, Matias-Guiu X, Prat J.
    Hum Pathol; 2002 Feb 15; 33(2):206-12. PubMed ID: 11957146
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. beta-Catenin nuclear accumulation in head and neck mucoepidermoid carcinoma: its role in cyclin D1 overexpression and tumor progression.
    Shiratsuchi H, Nakashima T, Hirakawa N, Toh S, Nakagawa T, Saito T, Tsuneyoshi M, Komune S.
    Head Neck; 2007 Jun 15; 29(6):577-84. PubMed ID: 17315172
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.